Back to Studies

P1084s / Maternal Infant TDF Toxicity Safety

Maternal and Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The Bone and Kidney Health Substudy of PROMISE Protocol: Promoting Maternal and Infant Survival Everywhere

Study Status

Closed to Follow Up

DAIDS Number


IND Number


Clinical Trials Link


P1084s is a nested, comparative substudy of HIV-1-infected women and their infants randomized in PROMISE to receive a maternal tenofovir-containing regimen or no maternal tenofovir-containing regimen during pregnancy or breastfeeding for prevention of mother-to-child transmission. This substudy is designed to examine bone, renal and growth outcomes of tenofovir exposure during pregnancy or during breastfeeding in 1077BF and 1077FF.

Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...